Zofran and Panthenol drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zofran (ondansetron hydrochloride) and Panthenol (pantothenic acid (vitamin b5)). Common drug interactions include pulmonary embolism among females and fungal oesophagitis among males.

The phase IV clinical study analyzes what interactions people have when they take Zofran and Panthenol. It is created by eHealthMe based on reports of 78 people who take the same drugs from the FDA, and is updated regularly.

What is Zofran?

Zofran has active ingredients of ondansetron hydrochloride. It is often used in nausea. eHealthMe is studying from 94,987 Zofran users. Check the latest studies of Zofran.

What is Panthenol?

Panthenol has active ingredients of pantothenic acid (vitamin b5). eHealthMe is studying from 2,079 Panthenol users. Check the latest studies of Panthenol.

On Jul, 11, 2026

78 people who take Zofran and Panthenol together, and have interactions are studied.

What are the common drug interactions of Zofran and Panthenol, by gender? *:

female:

Pulmonary embolism (blockage of the main artery of the lung)
Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
Renal cell carcinoma (a kidney cancer)
Renal tubular disorder (disease of kidney tubules)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Somnolence (a state of near-sleep, a strong desire for sleep)
Staphylococcus test positive
Venous thrombosis limb (blood clot that forms in a vein in the limb)
Diarrhoea
C-reactive protein increased

male:

Fungal oesophagitis (fungal inflammation of the oesophagus)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Asthenia (weakness)
Drug ineffective
Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles)
Interstitial lung disease
Leukopenia (less number of white blood cells in blood)
Lung adenocarcinoma (a form of non-small cell lung cancer)
Malignant neoplasm of pleura (cancer tumour of lung covering)
Malignant neoplasm progression (cancer tumour came back)

What are the common drug interactions of Zofran and Panthenol, by age (0-1 to 60+)? *:

0-1:

Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)

2-9:

Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)

10-19:

n/a

20-29:

Anaemia (lack of blood)
Febrile neutropenia (fever with reduced white blood cells)
Bone marrow toxicity (decrease in cells responsible for providing immunity, carrying oxygen, and those responsible for normal blood clotting)
Dermatitis exfoliative (widespread scaling of the skin, often with itching (pruritus), skin redness (erythroderma), and hair loss)
Dyspnoea (difficult or laboured respiration)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Hepatitis cholestatic (flow of bile from the liver is slowed or blocked)
Hepatosplenomegaly (enlargement of both the liver and the spleen)
Lymphadenopathy (disease or enlargement of lymph nodes)

30-39:

n/a

40-49:

Pancreatitis (inflammation of pancreas)
Febrile neutropenia (fever with reduced white blood cells)
Hypertension (high blood pressure)
Septic shock (shock due to blood infection)

50-59:

Diarrhoea
C-reactive protein increased
Dyspnoea (difficult or laboured respiration)
Tumour pain
Febrile neutropenia (fever with reduced white blood cells)
Overdose
Stomatitis (inflammation of mucous membrane of mouth)
Breast cancer metastatic
Pain of skin
Colitis (inflammation of colon)

60+:

Fungal oesophagitis (fungal inflammation of the oesophagus)
Thrombocytopenia (decrease of platelets in blood)
Oesophageal candidiasis (fungal infection of oesophagus)
Oropharyngeal pain
Adrenocortical insufficiency acute (suddenly adrenal glands do not produce adequate amounts of steroid hormones)
Bacterial test positive
C-reactive protein increased
Decreased appetite
Muscular weakness (muscle weakness)
Serum ferritin increased

What are the existing conditions these people have? *

Breast Cancer: 31 people, 39.74%
Conjunctivitis (pink eye): 23 people, 29.49%
Nail Abnormalities (abnormal nail): 17 people, 21.79%
Constipation: 15 people, 19.23%
Diarrhea: 14 people, 17.95%
Pain: 11 people, 14.10%
Itching: 10 people, 12.82%
Dyspnea (difficult or laboured breathing): 9 people, 11.54%
Dizziness: 8 people, 10.26%
Pneumonia: 7 people, 8.97%

* Approximation only. Some reports may have incomplete information.

Do you take Zofran and Panthenol?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously